See the DrugPatentWatch profile for Levophed
How does Levophed (norepinephrine) work in the body?
Levophed (norepinephrine) is a vasopressor that raises blood pressure by acting mainly on alpha-adrenergic receptors in blood vessels. It causes peripheral vasoconstriction, which increases systemic vascular resistance and helps restore adequate blood flow during states of shock.
Which receptors does Levophed target?
Norepinephrine’s key actions come from adrenergic receptor stimulation:
- Alpha-1 receptors (on vascular smooth muscle): causes vasoconstriction, increasing blood pressure.
- Beta receptors: it has weaker effects here than its alpha-1 effects in typical clinical vasopressor dosing, so the dominant clinical effect is increased vascular tone rather than strong “pump” stimulation.
What is the clinical effect of that mechanism?
By increasing vascular resistance and blood pressure, norepinephrine helps improve perfusion of vital organs in hypotensive, shock-related situations where blood pressure is too low. This is why it’s used when clinicians need a strong support of systemic arterial pressure.
How does Levophed compare with dopamine or epinephrine (mechanism-wise)?
Compared with agents that have stronger beta effects, norepinephrine is chosen when the priority is raising vascular tone and blood pressure through alpha-driven vasoconstriction. Dopamine and epinephrine can exert more mixed beta (and sometimes different receptor) effects depending on dose, which can shift the balance toward heart rate and contractility.
What happens if alpha vasoconstriction is too strong?
If peripheral vasoconstriction becomes excessive, patients can develop reduced blood flow to extremities and organs, contributing to complications like tissue ischemia. Clinicians therefore titrate dosing to achieve target blood pressure and perfusion with careful monitoring.
Sources
No sources were provided with the prompt.